FTRE·Nasdaq·US
Fortrea
Fortrea is a global contract research organization that provides clinical development and trial-management services to pharmaceutical, biotechnology, and medical device customers. The company also supports laboratory and related research workflows through partnerships and customer relationships in the life sciences ecosystem.
Recent Activity
Updated Oct 24, 2026
–Fortrea completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials, expanding its early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated offering.
–Fortrea announced a collaboration with Omico to advance biomarker-led oncology drug development, aiming to improve trial planning and expand patient access to biomarker-matched studies in Australia.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.